# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001171843-16-011576
Filing Date
2016-08-08
Accepted
2016-08-08 15:40:19
Documents
51
Period of Report
2016-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | FORM 10-Q | f10q_080816p.htm | 10-Q | 567038
2 | EXHIBIT 10.1 | exh_101.htm | EX-10.1 | 948
3 | EXHIBIT 10.2 | exh_102.htm | EX-10.2 | 236996
4 | EXHIBIT 10.3 | exh_103.htm | EX-10.3 | 1377
5 | EXHIBIT 31.1 | exh_311.htm | EX-31.1 | 9820
6 | EXHIBIT 31.2 | exh_312.htm | EX-31.2 | 9859
7 | EXHIBIT 32.1 | exh_321.htm | EX-32.1 | 3913
8 | EXHIBIT 32.2 | exh_322.htm | EX-32.2 | 3558
15 | GRAPHIC | exh101_1.jpg | GRAPHIC | 183808
16 | GRAPHIC | exh101_2.jpg | GRAPHIC | 119962
17 | GRAPHIC | exh103_1.jpg | GRAPHIC | 183482
18 | GRAPHIC | exh103_2.jpg | GRAPHIC | 168563
19 | GRAPHIC | exh103_3.jpg | GRAPHIC | 97194
20 | GRAPHIC | exh102_1.jpg | GRAPHIC | 162125
21 | GRAPHIC | exh102_2.jpg | GRAPHIC | 117386
| Complete submission text file | 0001171843-16-011576.txt |  | 5323905

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL INSTANCE FILE | bcrx-20160630.xml | EX-101.INS | 588437
10 | XBRL SCHEMA FILE | bcrx-20160630.xsd | EX-101.SCH | 44973
11 | XBRL CALCULATION FILE | bcrx-20160630_cal.xml | EX-101.CAL | 35263
12 | XBRL DEFINITION FILE | bcrx-20160630_def.xml | EX-101.DEF | 330613
13 | XBRL LABEL FILE | bcrx-20160630_lab.xml | EX-101.LAB | 317451
14 | XBRL PRESENTATION FILE | bcrx-20160630_pre.xml | EX-101.PRE | 333123

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-23186 | Film No.: 161813997
SIC: 2836 Biological Products, (No Diagnostic Substances)